Singapore-based ride-hailing and food delivery giant Grab could raise at least $2 billion with its intended initial public offering in the US this year, marking the largest overseas share offering by a Southeast Asian company.
According to sources, the size of the issue and period have not been finalized and are subject to market conditions.
Grab, which is present in eight Southeast Asian countries, has grown to become the region’s most valuable startup worth more than $16 billion since its founding in 2012 as a ride-hailing venture in Malaysia.
The company now offers financial services and recently received a digital bank license in Singapore in partnership with Singtel.
Grab's ride-hailing business is breaking even in all its operating markets and expects its food delivery business to likewise break even by the end of the year.
Grab's backers include SoftBank Group Corp and Mitsubishi UFJ Financial Group.


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



